CSIMarket
 


Immunomedics Inc   (IMMU)
Other Ticker:  
 

Cumulative Immunomedics Inc 's Leverage Ratio for Trailing Twelve Months Period

IMMU's Leverage Ratio for Trailing Twelve Months Period and Total Liabilities, Equity growth


Select the Comparisons : Select the Ratio:

IMMU Leverage Ratio for Trailing Twelve Months Period

(Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
(Dec 31 2019)
IV. Quarter
(Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
Y / Y Equity Growth 416.96 % 1.71 % 0.52 % -93.12 % -71.34 %
Y / Y Total Liabilities Growth 29.68 % 469.85 % 899.32 % 42.77 % 451.38 %
Leverage Ratio for Trailing Twelve Months Period 1.54 2.61 2.06 1.45 0.82
Total Ranking # 2304 # 3190 # 3204 # 2893 # 2258
Seq. Equity Growth 220.28 % -30.8 % 1044.16 % -79.61 % -36.99 %
Seq. Total Liabilities Growth 15.52 % 0.16 % 4.1 % 7.67 % 407.6 %


Leverage Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Jun 30 2020
On the trailing twelve months basis Despite net new borrowings of 15.52% Immunomedics Inc managed to decrease Leverage Ratio for Trailing Twelve Months Period in II. Quarter to 1.54, below Immunomedics Inc 's average Leverage Ratio for Trailing Twelve Months Period.
Leverage Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in In Vitro & In Vivo Diagnostic Substances industry 13 other companies have achieved lower Leverage Ratio for Trailing Twelve Months Period than Immunomedics Inc . While total ranking remained unchanged compare to previous quarter at no. .

What is Leverage Ratio?
Who are IMMU's Customers?
Leverage Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 14
Sector # 470
S&P 500 # 1290


Leverage Ratio for Trailing Twelve Months Period Statistics
High Average Low
5.56 1.69 0.2
(Jun 30 2015)   (June 30. 2014)




Companies with similar average Leverage Ratio for Trailing Twelve Months Period for 12 months ending Jun 30 2020, within In Vitro & In Vivo Diagnostic Substances Industry Leverage Ratio for Trailing Twelve Months Period
Immunomedics Inc   1.75 
Lantheus Holdings Inc   1.51 
Aspira Women s Health Inc   0.80 
Nymox Pharmaceutical Corporation  0.76 
Meridian Bioscience Inc   0.69 
Quidelortho Corp  0.62 
Myriad Genetics Inc   0.48 
Volitionrx Limited  0.48 
Biomerica Inc   0.39 
Oncocyte Corporation  0.39 
Immucell Corp  0.38 
Heska Corporation  0.35 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com